Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Bullboard Posts
Post by Tson99on Apr 23, 2013 1:00pm
142 Views
Post# 21292690

From the Globe and Mail article

From the Globe and Mail article

I find this interesting....

 

Bioniche chairman James Rae and Mr. McRae, Bioniche’s CEO, declined to comment on the shareholder letter. But in a news release the company said it is aware of the issues around the stock’s performance and that the board has been working over several months to “unlock the inherent value in the company’s assets.”

It said Bioniche has received “several strategic partnering and investment related offers” that are currently under review, there have been talks with outside advisers, and a major U.S. investment bank is being hired.

https://www.theglobeandmail.com/report-on-business/investment-group-urges-bioniche-to-narrow-focus/article11451615/

 

Bullboard Posts